Grupo de Apoio ao Adolescente e a Crianca com Cancer
9
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
33%
3 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
ALI (Acute Lung Injury) /ARDS (Acute Respiratory Distress Syndrome) in Oncologic Pediatric Patients
Role: lead
Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma
Role: lead
Prospective Clinical Trial Evaluating Metronomic Chemotherapy in Patients With High-grade, Operable, Non-metastatic Osteosarcoma of the Extremity
Role: lead
Evaluation of Fluid Resuscitation in Children With Cancer With Severe Sepsis / Septic Shock
Role: lead
Vancomycin Serum Concentrations in Pediatric Oncology Patients Under Intensive Care
Role: lead
Totally Implantable Catheters in Pediatric Hematology-oncology: a Study on Infectious Complications
Role: lead
Enteral Nutrition Support in Children and Adolescents With Cancer
Role: lead
Enteral Nutrition in Cancer Patients
Role: lead
Enteral Nutrition in Cancer Patient
Role: lead
All 9 trials loaded